Vir Biotechnology, Inc. Announces the Appointment of Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer, Effective July 10, 2023
June 29, 2023 at 03:22 pm EDT
Share
Vir Biotechnology, Inc. announced the appointment of Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer, effective July 10, 2023. Ms. Damouni Ellis will be responsible for the Companys strategic approach to corporate communications, government affairs, investor relations and patient advocacy, as well as for establishing Virs corporate social responsibility and environmental, social and governance efforts. She will report to Virs Chief Executive Officer Marianne De Backer, M.Sc., Ph.D., MBA, and will join the Companys Executive Management Team.
Sasha has an impressive track record as both a corporate communications and investor relations leader.
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Vir Biotechnology, Inc. Announces the Appointment of Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer, Effective July 10, 2023
VIR BIOTECHNOLOGY, INC. 
